Last reviewed · How we verify
ACE inhibitor ,angiotensin receptor blockers
ACE inhibitor ,angiotensin receptor blockers is a Small molecule drug developed by Ain Shams University. It is currently in Phase 2 development.
At a glance
| Generic name | ACE inhibitor ,angiotensin receptor blockers |
|---|---|
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Acute Kidney Injury
- Hypotension
- Septic shock
- Cellulitis
- Stroke
- Hyponatremia
- Hyperkalemia
- Urine albumin/creatinine ratio increased
- Hyperkalaemia
- Renal impairment
- Haematuria
- Glomerular filtration rate decreased
Key clinical trials
- Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES) (NA)
- A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease (PHASE1, PHASE2)
- Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
- Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN (PHASE2)
- Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria (PHASE3)
- The GUARDIAN Pilot Trial (NA)
- A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ACE inhibitor ,angiotensin receptor blockers CI brief — competitive landscape report
- ACE inhibitor ,angiotensin receptor blockers updates RSS · CI watch RSS
- Ain Shams University portfolio CI
Frequently asked questions about ACE inhibitor ,angiotensin receptor blockers
What is ACE inhibitor ,angiotensin receptor blockers?
ACE inhibitor ,angiotensin receptor blockers is a Small molecule drug developed by Ain Shams University.
Who makes ACE inhibitor ,angiotensin receptor blockers?
ACE inhibitor ,angiotensin receptor blockers is developed by Ain Shams University (see full Ain Shams University pipeline at /company/ain-shams-university).
What development phase is ACE inhibitor ,angiotensin receptor blockers in?
ACE inhibitor ,angiotensin receptor blockers is in Phase 2.
What are the side effects of ACE inhibitor ,angiotensin receptor blockers?
Common side effects of ACE inhibitor ,angiotensin receptor blockers include Acute Kidney Injury, Hypotension, Septic shock, Cellulitis, Stroke, Hyponatremia.